What is MS Phase 3 Fingolimod FREEDOMS?
CATEGORY:
TYPES:Generic: Fingolimod Clinical Trial
NCT00289978 is a completed 24-month, double-blind, randomized study comparing the efficacy and safety of fingolimod 1.25 mg and 0.5 mg administered orally once daily versus placebo in patients with relapsing-remitting multiple sclerosis. Other study names are ID#CFTY720D2301 and FREEDOMS.
Save up to 80% off your prescriptions!
How do members experience MS Phase 3 Fingolimod FREEDOMS?
Top 5 reported purposes & perceived effectiveness
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 1 | 0 |
Learn more about our community’s experience with MS Phase 3 Fingolimod FREEDOMS
What are people saying about MS Phase 3 Fingolimod FREEDOMS?
2
2
members have reported taking MS Phase 3 Fingolimod FREEDOMS
Join the conversation and connect with people who have taken MS Phase 3 Fingolimod FREEDOMS
Last updated: